These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 80976)

  • 1. [Value of alpha-2 globulin, as a biological tracer in the urothelial carcinoma].
    Gastón de Iriarte E; López-García JA; Hidalgo L; Mendoza M; Martínez-Piñeiro JA
    Arch Esp Urol; 1978; 31(3):225-34. PubMed ID: 80976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Value of alpha-globulin as a biological tracer in urogenital cancer].
    Gastón de Iriarte E; López-García JA; Hidalgo L; Mendoza M; Martínez-Piñeiro JA
    Actas Urol Esp; 1978; 2(3):119-26. PubMed ID: 79304
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunophenotype of high-grade prostatic adenocarcinoma and urothelial carcinoma.
    Genega EM; Hutchinson B; Reuter VE; Gaudin PB
    Mod Pathol; 2000 Nov; 13(11):1186-91. PubMed ID: 11106075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Plasma and urinary CEA-assay in patients with urological tumours (author's transl)].
    Hering H; Hering FJ; Weidner W
    Urologe A; 1976 Nov; 15(6):300-3. PubMed ID: 1006894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological surveillance and -globulin.
    Ablin RJ
    Isr J Med Sci; 1973 Apr; 9(4):480-3. PubMed ID: 4122703
    [No Abstract]   [Full Text] [Related]  

  • 6. [Quantitative evaluation of immunoglobulins in patients with bladder carcinoma].
    Maver A; Martinell A
    Cancro; 1969; 22(6):607-11. PubMed ID: 4104216
    [No Abstract]   [Full Text] [Related]  

  • 7. Carcinoembryonic antigen and urothelial carcinoma.
    Hall RR; Laurence DJ; Neville AM; Wallace DM
    Br J Urol; 1973 Feb; 45(1):88-92. PubMed ID: 4690154
    [No Abstract]   [Full Text] [Related]  

  • 8. Urothelial carcinoma of the prostate.
    Goebbels R; Amberger L; Wernert N; Dhom G
    Appl Pathol; 1985; 3(4):242-54. PubMed ID: 3842265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Value of carcinoembryonic antigen (CEA) in the diagnosis of malignant tumors of the urogenital tract].
    Rost A; Kneppenberg U; Rost P
    Helv Chir Acta; 1976 Jul; 43(3):271-8. PubMed ID: 947865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-1 alpha and interleukin-1 beta production in peripheral whole blood from patients with urological cancer.
    Kuo JY; Ohmoto Y; Yoshida O
    Hinyokika Kiyo; 1998 Jun; 44(6):397-402. PubMed ID: 9719938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunochemical studies of tissue alpha2 globulin in neoplastic and normal tissues of human kidney].
    Prokopenko PG; Tatarinov IuS
    Biull Eksp Biol Med; 1973 Aug; 76(8):102-5. PubMed ID: 4130348
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunologic features of genitourinary cancer.
    Javadpour N
    Urology; 1973 Aug; 2(2):103-8. PubMed ID: 4129366
    [No Abstract]   [Full Text] [Related]  

  • 13. Small cell carcinoma of the urinary bladder: a clinicopathologic analysis of 64 patients.
    Cheng L; Pan CX; Yang XJ; Lopez-Beltran A; MacLennan GT; Lin H; Kuzel TM; Papavero V; Tretiakova M; Nigro K; Koch MO; Eble JN
    Cancer; 2004 Sep; 101(5):957-62. PubMed ID: 15329903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibodies to human prostate and bladder tumor-associated antigens.
    Starling JJ; Sieg SM; Beckett ML; Schellhammer PF; Ladaga LE; Wright GL
    Cancer Res; 1982 Aug; 42(8):3084-9. PubMed ID: 7046915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serum and urinary tissue polypeptide antigen (TPA) in patients with urological cancer].
    Kazama T; Katayama T; Yamazaki N
    Hinyokika Kiyo; 1985 Dec; 31(12):2113-9. PubMed ID: 3832915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
    Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
    Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavior of urothelial carcinoma with respect to anatomical location.
    Catto JW; Yates DR; Rehman I; Azzouzi AR; Patterson J; Sibony M; Cussenot O; Hamdy FC
    J Urol; 2007 May; 177(5):1715-20. PubMed ID: 17437794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray.
    Higgins JP; Kaygusuz G; Wang L; Montgomery K; Mason V; Zhu SX; Marinelli RJ; Presti JC; van de Rijn M; Brooks JD
    Am J Surg Pathol; 2007 May; 31(5):673-80. PubMed ID: 17460449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of CA-50 radioimmunoassay test in diagnosis of urologic malignancy. Tie for second place Jobst award.
    Hershman MJ; Habib NA; Ferro MA; Williamson RC; Wood CB
    Am Surg; 1987 Dec; 53(12):691-4. PubMed ID: 3480697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Detection of a prostatic adenocarcinoma in the cysto-prostatectomy specimens of an invasive tumor of the bladder].
    Baron JC; Zerbib M; Levêque JM; Deslignières S; Boccon-Gibod L; Debré B; Steg A
    Ann Urol (Paris); 1989; 23(2):119-22. PubMed ID: 2742333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.